340 related articles for article (PubMed ID: 1651302)
1. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy of brain tumors.
Sneed PK; Gutin PH; Prados MD; Phillips TL; Weaver KA; Wara WM; Larson DA
Stereotact Funct Neurosurg; 1992; 59(1-4):157-65. PubMed ID: 1338231
[TBL] [Abstract][Full Text] [Related]
3. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.
Leibel SA; Gutin PH; Wara WM; Silver PS; Larson DA; Edwards MS; Lamb SA; Ham B; Weaver KA; Barnett C
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1129-39. PubMed ID: 2557303
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
5. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.
Sneed PK; Gutin PH; Larson DA; Malec MK; Phillips TL; Prados MD; Scharfen CO; Weaver KA; Wara WM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):719-27. PubMed ID: 8040017
[TBL] [Abstract][Full Text] [Related]
7. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
8. High activity iodine-125 interstitial implant for gliomas.
Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
[TBL] [Abstract][Full Text] [Related]
9. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
10. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
Jeremic B; Jovanovic D; Djuric LJ; Jevremovic S; Mijatovic LJ
J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
[TBL] [Abstract][Full Text] [Related]
12. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023
[TBL] [Abstract][Full Text] [Related]
14. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience.
Prados MD; Gutin PH; Phillips TL; Wara WM; Sneed PK; Larson DA; Lamb SA; Ham B; Malec MK; Wilson CB
Int J Radiat Oncol Biol Phys; 1992; 24(4):593-7. PubMed ID: 1429080
[TBL] [Abstract][Full Text] [Related]
15. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.
Videtic GM; Gaspar LE; Zamorano L; Fontanesi J; Levin KJ; Kupsky WJ; Tekyi-Mensah S
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):687-92. PubMed ID: 10524423
[TBL] [Abstract][Full Text] [Related]
16. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Groves MD; Maor MH; Meyers C; Kyritsis AP; Jaeckle KA; Yung WK; Sawaya RE; Hess K; Bruner JM; Peterson P; Levin VA
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):127-35. PubMed ID: 10477016
[TBL] [Abstract][Full Text] [Related]
19. Permanent iodine-125 implants in the up-front treatment of malignant gliomas.
Fernandez PM; Zamorano L; Yakar D; Gaspar L; Warmelink C
Neurosurgery; 1995 Mar; 36(3):467-73. PubMed ID: 7753345
[TBL] [Abstract][Full Text] [Related]
20. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
